XOMA Royalty (XOMA) Other Non Operating Income (2011 - 2026)

XOMA Royalty (XOMA) reported Other Non Operating Income of $4.8 million for Q1 2026, up 5110.53% on a YoY basis from $91353.5 in Q1 2025, and up 580.0% sequentially from $700000.0 in Q4 2025.

XOMA Royalty (XOMA) Other Non Operating Income (2011 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 16 years of Other Non Operating Income data on file, last reported at $4.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income rose 5110.53% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $13.2 million (up 118.18% YoY), and the FY2025 full-year result was $93000.0, down 98.85% from the prior year.
  • Other Non Operating Income grew to $4.8 million in Q1 2026, from $700000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $7.8 million in Q2 2025 to a low of -$215000.0 in Q1 2022.
  • A 5-year average of $1.4 million and a median of $475500.0 in 2023 frame the typical range for Other Non Operating Income.
  • Across the five-year window, Other Non Operating Income plunged 104.85% in 2025 and soared 5110.53% in 2026, its largest moves.
  • Tracing XOMA's Other Non Operating Income over 5 years: stood at $219000.0 in 2022, then soared by 79.91% to $394000.0 in 2023, then surged by 458.38% to $2.2 million in 2024, then tumbled by 68.18% to $700000.0 in 2025, then soared by 580.0% to $4.8 million in 2026.
  • Business Quant data shows XOMA's Other Non Operating Income at $4.8 million in Q1 2026, $700000.0 in Q4 2025, and $7.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn -
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn
7 Belite Bio 63.28 Bn 63.28 Bn -
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn
9 Revolution Medicines 38.15 Bn 38.15 Bn -
10 XOMA Royalty 478.42 Mn 412.34 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4.76 Mn
Dec 31, 2025 700,000.00
Jun 30, 2025 7.82 Mn
Mar 31, 2025 -95,000.00
Dec 31, 2024 2.20 Mn
Sep 30, 2024 1.89 Mn
Jun 30, 2024 2.05 Mn
Mar 31, 2024 1.96 Mn
Dec 31, 2023 394,000.00
Sep 30, 2023 278,000.00
Jun 30, 2023 557,000.00
Mar 31, 2023 357,000.00
Dec 31, 2022 219,000.00
Sep 30, 2022 194,000.00
Jun 30, 2022 97,000.00
Mar 31, 2022 -215,000.00
Sep 30, 2021 -1.09 Mn
Jun 30, 2021 -300,000.00
Mar 31, 2021 -657,000.00
Dec 31, 2020 -821,000.00